Who We Are
About Us
The Organisation of Pharmaceutical Producers of India (OPPI) established in 1965, represents the research-based global pharmaceutical companies in India. OPPI has been an integral part of the healthcare journey of the country. We remain committed to supporting the nation’s healthcare objectives, putting patients at the core of all decision making and collaborating with all stakeholders to find sustainable solutions to realize the collective vision of Health for All.
Our member companies have been serving the country’s healthcare ecosystem since pre-independence and continue to remain committed to patient safety and providing quality care in the future as well. As an association, our advocacy decisions, patient commitment and work are always keeping the country first and we embody the spirit of working for ‘Bharat Ke Liye’; driven with innovation to find solutions for unmet medical needs, collaboration with government stakeholders, and co-creation with partners coming together to address the nation’s healthcare challenges. We are committed to the Hon’ble Prime Minister Shri Narendra Modi-ji’s clarion call of ‘Jai Vigyan and Jai Anusandhan’.
Vision
OPPI is an organisation of research and innovation driven pharmaceutical companies committed to addressing India’s healthcare needs by:
- Facilitating greater access to quality healthcare solutions
- Encouraging research and innovation
- Disseminating knowledge and sharing best practices
- Contributing meaningfully in policy dialogues
Mission
Building a healthier India through access to Innovation
OPPI Directorate
Experts
SHREYAS KALE
Director Finance & Administration And Association Secretary
Shreyas has more than two and a half decades of experience in Finance and Accounting. Shreyas leads the finance and administration function in OPPI overseeing the budget management, accounting, financial planning and analysis, and is also responsible for the smooth functioning of the Secretariat. Prior to OPPI, Shreyas has spent 21 years at Pfizer Ltd and has handled areas such as Financial Planning & Analysis, Budgeting, Forecasting, Long Range Planning, P&L Management, Pricing, Accounts Receivable & Cost Audit. A Cost Accountant from the Institute of Cost & Works Accountants of India (ICWAI), Shreyas started his career with Cadbury India Limited and has worked with Boehringer Mannheim Limited and Ciba Geigy Limited.
Experts
ASAWARI SATHAYE
Director, Communications & Patient Advocacy
As Director, Communications & Patient Advocacy, Asawari leads the Communications and Patient Advocacy programmes and is responsible for OPPI’s communications function and work on multi-stakeholder advocacy and social media engagements.
Asawari brings with her over 13 years of experience across communication and investor relations domains. Prior to joining OPPI, she was the head of corporate communications, investor relations and sustainability at Shoppers Stop, and had led the corporate communications and investor relations functions in Voltas Limited. She had also worked with PwC as a senior consultant and with Tata Services as an Economist.
Through her career, she has been actively engaged with both internal & external stakeholders, built digital presence, set up brand management and guidelines, increased brand visibility and equity. She has notable acumen in developing and implementing communication campaigns, leading investor relations and supporting advocacy programmes.
An alumni of the Indian School of Business (ISB), she is also a member of its PGP Learning and Advisory council.
Experts
PRASHANT SHARMA
Director - Government Affairs
With over 28 years of experience in medical device & pharmaceuticals industry, Prashant is a competent and purpose driven public health professional offering exposure in driving Public policy advocacy, Government Affairs and Market Access. In his previous roles he has worked with Astra Zeneca, BMS, Biocon, Boehringer Ingelheim, MSD, and Wyeth. His last assignment was with India Medtronic as Lead Market Access & Government Affairs.
Prashant is a Science graduate with PGDBM from Symbiosis Pune.
Members
OPPI member companies invest in the research of new medicines. They are pioneers in innovation, ushering in a new era of treatment for patients. Over the decades, OPPI member companies have laid a strong foundation for the development of a world class and robust pharmaceutical industry in the country.
If your company is interested in joining OPPI.
Click here
To know more about OPPI Members Click here
Past Presidents
| Name | Company | Year |
|---|---|---|
| Suresh Pattathil | AbbVie | 2022 - 2024 |
| S Sridhar | Pfizer | 2021-2022 |
| Sharad Tyagi | Boehringer Ingelheim | 2020- 2021 |
| A. Vaidheesh | GlaxoSmithKline | 2017 - 2020 |
| Dr. Shailesh Ayyangar | Sanofi | 2013 - 2017 |
| Late Ranjit Shahani | Novartis | 2009 - 2013 |
| Ranga Iyer | Wyeth | 2007 - 2009 |
| Late Ranjit Shahani | Novartis | 2001 - 2007 |
| Tapan Ray | Abbott | Sept. - Nov. 2001 |
| Late Mr P. Gupta | Infar | 2000 - 2001 |
| H.R. Khusrokhan | Glaxo | 1998 - 2000 |
| D. Bhadury | Hoechst Marion Roussel | 1996 - 1998 |
| Dr Anil S. Mehta | Wyeth | 1994 - 1996 |
| H. Dhanrajgir | Glaxo | 1992 - 1994 |
| D.K. Bose | Burroughs Wellcome | 1990 - 1992 |
| Dr S. Agarwala | Rallis | 1988 - 1990 |
| C.M. Hattangdi | Parke - Davis | 1986 - 1987 |
| R.N. Langrana | Abbott | 1985 |
| Late Mr George Daniel | Hoechst | 1982 - 1984 |
| Late Dr S.K. Bhattacharya | Sandoz | 1980 - 1981 |
| Late Mr H.N. Dutt Gupta | East India Pharmaceutical Works | 1979 |
| Late Mr Sisir Mitra | Cyanamid | 1976 - 1978 |
| S.V. Pillai | Pfizer | 1974 - 1975 |
| Late Brig. B. S. Bhagat | Rallis | 1970 - 1973 |
| Keith C. Roy | Merck Sharp Dohme | 1967 - 1969 |
| Late Dr H.R. Nanji | Pharmed | 1966 |